Oximetría de pulso y su relación con la detección precoz de enfermedad cardiaca en neonatos

  1. Gema Arévalo-Arévalo
  2. José Vicente Carmona-Simarro
Zeitschrift:
Metas de enfermería

ISSN: 1138-7262

Datum der Publikation: 2019

Ausgabe: 22

Nummer: 2

Seiten: 27-32

Art: Artikel

DOI: 10.35667/METASENF.2019.22.1003081368 DIALNET GOOGLE SCHOLAR

Andere Publikationen in: Metas de enfermería

Ziele für nachhaltige Entwicklung

Zusammenfassung

Objective: to analyze the scientific evidence about the use of pulse oximetry for heart disease screening in newborns. Method: a narrative review of scientific literature was conducted through bibliographic search of indexed articles in the PubMed database, limited to the English and Spanish languages, and published in the past two years (2016-2018). The health descriptors from the Medical Subject Headings (MeSH) were used for the bibliographic search, and the following terms were used in combination with the Boolean operator AND: “Oximetry AND Congenital Heart AND neonatal screening”. Documents with low scientific evidence were excluded, such as expert opinions and editorials. Results: twelve (12) relevant studies were identified. From the review conducted, it can be highlighted that pulse oximetry testing routinely conducted in newborns (NBs) will increase the sensitivity for detecting children with Congenital Heart Disease (CHD), even for those who are asymptomatic. An early diagnosis of CHD in NBs will improve morbimortality results in this age group. At the same time, healthcare expenses will be reduced with an early detection of CHD cases in NBs; otherwise, this would represent a very high cost in terms of their life-long treatment. Conclusions: pulse oximetry is a technique supporting the early diagnosis of CHD in NBs, mostly in those situations where there is no complementary technology for a final diagnosis.

Bibliographische Referenzen

  • Tobe RG, Martin GR, Li F, Moriichi A, Wu B, Mori R. Cost-effectiveness analysis of neonatal screening of critical congenital heart defects in China. Medicine (Baltimore). 2017; 96(46):e8683. doi: 10.1097.
  • Kumar P. Universal pulse oximetry screening for early detection of critical congenital heart disease. Clin Med Insights Pediatr. 2016; 10:35-41.
  • Plana MN, Zamora J, Suresh G, Fernández-Pineda L, Thangaratinam S, Ewer AK. Pulse oximetry screening for critical congenital heart defects. Cochrane Database Syst Rev. 2018;3:CD011912. doi: 10.1002/14651858.C D011912.pub2.
  • Al-Mukhaini KS, Mohamed AM. Transposition of the great arteries and coarctation of the aorta in an infant presenting with bronchiolitis: an incidental finding. Sultan Qaboos Univ Med J. 2017;17(3):e348-e351. doi: 10.18295/squmj.17.03.016.
  • Johnson LC, Lieberman E, O’Leary E, Geggel RL. Prenatal and newborn screening for critical congenital heart disease: findings from a nursery. Pediatrics 2014 Nov; 134(5): 916-22. doi: 10.1542/peds. 2014-1461.
  • Miller KK, Vig KS, Goetz EM, Spicer G, Yang AJ, Hokanson JS. Pulse oximetry screening for critical congenital heart disease in planned out of hospital births and the incidence of critical congenital heart disease in the Plain community. J Perinatol. 2016; 36(12):1088-91. doi: 10.1038/jp.2016.135.
  • Grosse SD, Riehle-Colarusso T, Gaffney M, Mason CA, Shapira SK, Sontag MK, et al. CDC grand rounds: newborn screening for hearing loss and critical congenital heart disease. MMWR Morb Mortal WklyRep.2017; 66(33): 888-90. doi: 10.15585/mmwr.mm6633a4.
  • De-Wahl Granelli A, Wennergren M, Sandberg K, Mellander M, Bejlum C, Inganas L, et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ. 2009; 338:a3037.
  • Ewer AK, Middleton LJ, Furmston AT, Bhoyar A, Daniels JP, hangaratinam S, et al. Pulse oximetry screening for congenital heart defects in newborn infants (Pulse Ox): a test accuracy study. Lancet. 2011; 378:785-94.
  • Zhao QM, Ma XY, Ge XL, Liu F, Yan WL, Wu L, et al. Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a perspective study. Lancet. 2014; 384:747-54.
  • Hoffman JI. The challenge in diagnosing coarctation of the aorta. Cardiovasc J Afr. 2017; 28:1-4. doi: 10.5830/CVJA-053.
  • Hu XJ, Zhao QM, Ma XJ, Yan WL, Ge XL, Jia B, et al. Pulse oximetry could significantly enhance the early detection of critical congenital heart disease in neonatal intensive care units. Acta Paediatr. 2016; 105(11):e499-e505. doi: 10.1111/apa.13553.
  • PRISMA. Transparent reporting of systematic Reviews and Meta-analyses [internet] [cited 13 dic 2018]. Available from: http://www.prisma-statement.org/index.htm
  • Scottish Intercollegiate Guidelines Network (SIGN). SIGN 50: a guideline developer’s handbook [internet]. Edinburgh: SIGN; 2008 [cited 13 dic 2018]. Available from: https://www.sign.ac.uk/assets/sign50_2015.pdf
  • Mawson IE, Babu PL, Simpson JM, Fox GF. Pulse oximetry findings in newborns vihzantenataly diagnose congenital heart diasease. Eur J Pediatr. 2018. doi: 10.1007/s00431-018-3093-2.
  • Hamilçıkan S, Can E. Critical congenital heart disease screening with a pulse oximetry in neonates. J Perinat Med. 2018; 46(2):203-7. doi: 10.1515/jpm-2017-0006.
  • Cloete E, Gentles TL, Alsweiler JM, Dixon LA, Webster DR, Rowe DL, et al. Should New Zealand introduce nationwide pulse oximetry screening for the detection of critical congenital heart disease in newborn infants? N Z Med J. 2017; 130(1448):64-9.
  • Jones AJ, Howarth C, Nicholl R, Mat-Ali E, Knowles R. The impact and efficacy of routine pulse oximetry screening for CHD in a local hospital. Cardiol Young. 2016; 26(7): 1397-405. doi: 10.1017/S1047951115002784.
  • Movahedian AH, Mosayebi Z, Sagheb S. Evaluation of pulse oximetry in the early detection of cyanotic congenital heart disease in newborns. J Tehran Heart Cent. 2016; 11(2):73-8.
  • Grosse SD, Peterson C, Abouk R, Glidewell J, Oster ME. Cost and cost-effectiveness assessments of newborn screening for critical congenital heart disease using pulse oximetry: a review. Int J Neonatal Screen. 2017; 3 (4):34. doi: 10.3390/ijns3040034.
  • Sánchez M, Pérez A, Sanz E, Leante JL, Benavente I, Ruiz C, et al. Cribado de cardiopatías congénitas críticas en el periodo neonatal. Recomendación de la Sociedad Española de Neonatología. An Pediatr (Barc). 2018; 88(2): 112.e1-112.e6.
  • Methlouthi J, Mahdhaoui N, Bellaleh M, Guith A, Zouari D, Ayech H, Nouri S, Séboui H. Incidence of congenital heart disease in newborns after pulse oximetry screening introduction. Tunis Med. 2016; 94(3):231-4.
  • Hom LA, Martin GR. Newborn critical congenital heart disease screening using pulse oximetry: nursing aspects. Am J Perinatol. 2016; 33(11):1072-5. doi: 10.1055/s-00 36-1586108.
Fuente de los datos: Dialnet